The U.S. Supreme Court's decision Tuesday that America Invents Act reviews do not violate the U.S. Constitution preserves the system for challenging patents, but the narrow decision will likely prompt more constitutional challenges to procedures used in the reviews, attorneys say.
Prominent fund Fisher Investments has secured promises from several former employees accused of breaching confidentiality agreements that they would cease to use or divulge private information about Fisher Investments clients.
Sun Microsystems Inc. and rival computer company Azul Systems Inc. said Tuesday that they had settled a patent infringement and trade secret misappropriation lawsuit that had dragged on for more than a year.
A chemicals company has filed a lawsuit against Noven Pharmaceuticals Inc. asserting a patent related to the delivery of a stimulant through a transdermal patch.
In a blow to Novartis AG, an appeals court has shot down the pharmaceutical company's request to review the reinstatement of a patent challenge brought by Israel's Teva Pharmaceutical Industries Ltd. over the Swiss drug maker's genital herpes drug Famvir.
Abbott Laboratories filed a patent suit Monday against generics maker Impax Laboratories Inc., increasing its efforts to protect the multimillion-dollar U.S. market for its epilepsy and migraine treatment Depakote.
Just days after suing Sandoz Inc., Sanofi-Aventis U.S. LLC stepped up its efforts to fend off generics Monday and made Israeli giant Teva Pharmaceutical Industries Ltd. the newest target of its Eloxatin patent infringement accusations.
Citing safety concerns and economic harm, a wireless industry trade group requested Wednesday that President George W. Bush veto a federal trade agency ruling which banned the importation of new cell phones containing Qualcomm Inc. chips.
The Supreme Court on Monday dealt a fatal blow to Israel Bio-Engineering Project's patent infringement case against Amgen Inc., letting stand an appellate court ruling that IBEP cannot sue because it cannot prove it is the patent's sole owner.
Fresh off its $150 million patent infringement win against Sony Corp., software developer Immersion Corp. is now being sued for allegedly breaching a sublicense agreement with Microsoft Corp.
Biotech company Biomedino LLC's patent on a method for cleaning drugs out of blood was found invalid by the Court of Appeals for the Federal Circuit on Monday, on the grounds that it did not disclose the structure of a crucial valve.
Microsoft Corp. has fired back at a patent holding company that accused the computer giant of fraudulently acquiring a portfolio of interactive television technology patents without a per-product royalty rate.
A record number of patent filings were lodged with the European Patent Office last year, with U.S. firms proving once again to be the most prolific applicants, according to figures released Monday.
Advanced Micro Devices pushed Monday for a stay in a patent lawsuit brought by a rival chip in the wake of a mass rejection of the claims by the U.S. Patent & Trademark Office.
An appeals court granted Parker Hannifin Corp. a victory in a patent suit over pipe-fitting technology, vacating an injunction that barred Parker Hannifin from selling products alleged to infringe two patents owned by OmegaFlex Inc. and reversing a lower court's decision to grant summary judgment of validity with respect to OmegaFlex's patents.
AOL LLC, Yahoo Inc., Verizon Wireless and several other technology giants that run photo-sharing Web sites were hit Monday with infringement suits for allegedly violating three patents over photo technology.
McDermott Will & Emery has pulled in two partners as the firm continues to build up its intellectual property, media and technology department.
Johnson & Johnson subsidiaries Ortho-McNeil Pharmaceuticals Inc. and Alza Corp. have again attempted to get a judge to toss a lawsuit over the bladder drug Ditropan XL, saying in a motion filed Monday that the only remaining plaintiff didn't directly purchase the product.
A California court has handed down a number of favorable and not so favorable summary judgment rulings for both parties involved in Semiconductor Energy Laboratory Ltd.’s patent infringement case against Chi Mei Optoelectronics Corp. over liquid crystal display devices.
The judge presiding over Rambus Inc.’s memory device patent infringement suit has refused to toss counterclaims alleging the chip maker restricted competition in the dynamic random access memory market.
Generic drug maker Apotex Inc. has vowed to appeal a judge's ruling Tuesday that the patent on Bristol-Myers Squibb Co.'s blockbuster blood thinner Plavix is valid and enforceable.